190 related articles for article (PubMed ID: 33832456)
1. A data-driven approach for the discovery of biomarkers associated with thyroid eye disease.
Zou H; Xu W; Wang Y; Wang Z
BMC Ophthalmol; 2021 Apr; 21(1):166. PubMed ID: 33832456
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of orbital soft tissue biomechanical parameters in patients with thyroid eye disease using the non-contact Corvis ST.
Moeen Rad A; Zarei-Ghanavati S; Sabermoghaddam A; Ghavami Shahri SH; Bakhtiari E; Kiarudi MY
Int Ophthalmol; 2023 Oct; 43(10):3615-3621. PubMed ID: 37393605
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.
Poon SHL; Cheung JJ; Shih KC; Chan YK
Rev Endocr Metab Disord; 2022 Jun; 23(3):541-567. PubMed ID: 35066781
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
Wall JR; Lahooti H
Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
[TBL] [Abstract][Full Text] [Related]
5. Identification of immune-related regulatory networks and diagnostic biomarkers in thyroid eye disease.
Tong X; Shen Q
Int Ophthalmol; 2024 Feb; 44(1):38. PubMed ID: 38332455
[TBL] [Abstract][Full Text] [Related]
6. Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss.
Park J; Baek S
Acta Ophthalmol; 2019 Aug; 97(5):e800-e806. PubMed ID: 30593716
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
Wall JR; Lahooti H
Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
[TBL] [Abstract][Full Text] [Related]
8. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
Edmunds MR; Boelaert K
Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
[TBL] [Abstract][Full Text] [Related]
9. Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease.
Chng CL; Seah LL; Yang M; Shen SY; Koh SK; Gao Y; Deng L; Tong L; Beuerman RW; Zhou L
Sci Rep; 2018 Nov; 8(1):16936. PubMed ID: 30446693
[TBL] [Abstract][Full Text] [Related]
10. Molecular Biomarkers in Thyroid Eye Disease: A Literature Review.
Ueland HO; Neset MT; Methlie P; Ueland GÅ; Pakdel F; Rødahl E
Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S19-S28. PubMed ID: 38054982
[TBL] [Abstract][Full Text] [Related]
11. Anatomic Considerations in Thyroid Eye Disease.
Dutton JJ
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S7-S12. PubMed ID: 29870437
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
14. Thyroid eye disease presenting with superior rectus/levator complex enlargement.
Wang Y; Mettu P; Broadbent T; Radke P; Firl K; Shepherd JB; Couch SM; Nguyen A; Henderson AD; McCulley T; McClelland CM; Mokhtarzadeh A; Lee MS; Garrity JA; Harrison AR
Orbit; 2020 Feb; 39(1):5-12. PubMed ID: 31056988
[No Abstract] [Full Text] [Related]
15. The eye and thyroid disease.
Kuriyan AE; Phipps RP; Feldon SE
Curr Opin Ophthalmol; 2008 Nov; 19(6):499-506. PubMed ID: 18854695
[TBL] [Abstract][Full Text] [Related]
16. Lysosome-related genes are regulated in the orbital fat of patients with graves' ophthalmopathy.
Chen MH; Liao SL; Chen MH; Tsou PL; Shih MJ; Chang TC; Chuang LM
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4760-4. PubMed ID: 18552385
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
[TBL] [Abstract][Full Text] [Related]
18. Novel inflammatory biomarkers in thyroid eye disease.
Ueland HO; Ueland GÅ; Løvås K; Breivk LE; Thrane AS; Meling Stokland AE; Rødahl E; Husebye ES
Eur J Endocrinol; 2022 Aug; 187(2):293-300. PubMed ID: 35675127
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of thyroid eye disease following extraocular muscle surgery.
Xu L; Glass LR; Kazim M
Ophthalmic Plast Reconstr Surg; 2014; 30(1):e5-6. PubMed ID: 23467286
[TBL] [Abstract][Full Text] [Related]
20. Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients.
Sagiv O; Kandl TJ; Thakar SD; Thuro BA; Busaidy NL; Cabanillas M; Jimenez C; Dadu R; Graham PH; Debnam JM; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2019; 35(1):50-52. PubMed ID: 29927883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
